Article
Wedbush Reiterates Outperform on Larimar Therapeutics, Maintains $11 Price Target
Wedbush analyst Laura Chico reiterates Larimar Therapeutics (NASDAQ:LRMR) with a Outperform and maintains $11 price target.
Comments
- No comments yet. Be the first to comment!